LAMP3 and breast cancer: Additionally, LAMP3+ DCs showed the highest level of CD274 (Fig. 2f), which was even higher than what was observed in Tregs from BC tissues, indicating that this DC subgroup could inhibit CD8+ T cells directly or via recruiting Tregs into the tumor region.